Vvus stock quote

VVUS Stock Quote of Vivus Inc - InvestorPlace

Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included. Description VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. VIVUS Inc., VVUS Quick Chart - (NAS) VVUS, VIVUS Inc ... VVUS - VIVUS Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Vivus Inc (VVUS-Q) Quote - The Globe and Mail Detailed price information for Vivus Inc (VVUS-Q) from The Globe and Mail including charting and trades. Skip to main content Get full access to globeandmail.com VVUS - Vivus Stock Price - Barchart.com

On average, they expect VIVUS's stock price to reach $1.75 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View analysts' price targets for VIVUS .

Get VVUS stock quote information for Vivus-Inc, including a stock overview, one-click scorecard, industry position, and the latest headlines. Stock Quote - Vivus-Inc Summary - Quicken® Investing Center VVUS - Vivus Stock Profile - Barchart.com Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. Price/Cash Flow - Latest closing price of the stock divided by the last twelve months revenue/cash flow per share. Price/Book - A financial ratio used to compare a company's current market price to … VIVUS (VVUS) Cash Flow | The Motley Fool Real time VIVUS (VVUS) Cash Flow. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Before You Buy VIVUS, Inc. (NASDAQ:VVUS), Consider Its ... Dec 24, 2019 · If you're interested in VIVUS, Inc. (NASDAQ:VVUS), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio.Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility.

VVUS.US | VIVUS Inc. Stock Price & News - WSJ

The VVUS ("VVUS" ) future stock price will be 5.035 USD . Will VVUS stock price crash? According to our analysis, this will not happen. Will VIVUS stock  Get breaking news and analysis on VIVUS, Inc. (VVUS) stock, price quote and chart, trading and investing tools. View the real-time VVUS price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying  This was a 1 for 10 reverse split, meaning for each 10 shares of VVUS owned Stock exchanges also tend to look at per-share price, setting a lower limit for  5 Nov 2007 Vivus (VVUS) · VVUS RSS Feed · Add VVUS Price Alert Hide Sticky Hide Intro. Moderator:. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it 

Vivus Inc (VVUS-Q) Quote - The Globe and Mail

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio By Zacks Investment Research May 25, 2017 VIVUS is a biopharmaceutical company developing and commercializing innovative, next VIVUS, Inc. (VVUS) stock price, quote, history & news ... VIVUS, Inc. (VVUS), a biopharmaceutical company, today announced the publication of a new study from the Toolbox Trial (NCT01922934), a real-world clinical trial conducted in urban safety-net primary care clinics offering patients a “toolbox” of cost-effective weight management tools.

VIVUS, Inc. (VVUS) Stock Analysis & News | Seeking Alpha

View a financial market summary for VVUS including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to VVUS (Vivus Inc.) stock.

By John Vandermosten, CFA NASDAQ:VVUS Vivus, Inc. (NASDAQ:VVUS) announced the pay down of $48.6 million of its senior secured notes due 2024. The securities were yielding 10.375% and their early retirement is expected to save Vivus $10.5 million over the term of the loan. Vivus has held substantial cash on its balance sheet and now VVUS Stock Price | VIVUS Inc. Stock Quote (U.S.: Nasdaq ... VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA.